Business
Allergic rhinitis vaccination website launched
Allergic rhinitis vaccination website launched.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n \nRNS Number : 4210E Allergy Therapeutics PLC 06 April 2011 \n \n\n6 April 2011\n \nAllergy Therapeutics plc\n(\"Allergy Therapeutics\" or \"the Company\")\n \nAllergic rhinitis vaccination website launched \n \n12 million Britons suffering from hay fever could benefit from vaccination\n \nAllergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, has launched a website to promote the use of hay fever vaccination in the UK, (www.pollinex.com).\n \nAlthough widely available across Western Europe and the US, historically, severe hay fever sufferers in the UK have had restricted access to curative vaccination treatment. Allergy Therapeutics' new website will attempt to educate hay fever sufferers, parents of young sufferers and GPs about the symptoms and treatment options increasingly available in the UK. \n \nIn the UK 20% of the population suffer from seasonal allergic rhinitis triggered by tree and grass pollen during spring and summer, imposing a strain on social lives, school performance and work productivity.1 This percentage of the population is set to grow at an average rate of 5% per annum in Europe, the US and Japan.2\n \nAllergy Therapeutics' website offers hay fever sufferers and GPs information on how to access vaccination, and the benefits of such treatment versus current treatment options. For moderate to severe cases of allergic rhinitis the Company's Pollinex® portfolio offers a much more convenient and effective treatment regime than is currently available. Pollinex® is the only registered subcutaneous immunotherapy available in the UK and consists of only 6 injections which can be administered in as little as 5 weeks.\n \n \nManuel Llobet, CEO of Allergy Therapeutics, commented:\n \n\"Thousands of people suffering from severe hay fever in the UK are unaware of the option of vaccination. We hope that our Pollinex.com website will provide a valuable tool for people suffering from allergies across the UK, allowing them to find the correct treatment solution that addresses the underlying cause of allergies, not just the symptoms.\"\n \n1 www.pollinex.com\n2 Nomura Code Securities research\n \n \n \nFor further information\n \n\n\n\n\nAllergy Therapeutics\n\n\n+44 (0) 1903 845 820\n\...